Mechanisms of action of cyclosporine.

Cyclosporine (cyclosporin A, CsA) has potent immunosuppressive properties, reflecting its ability to block the transcription of cytokine genes in activated T cells. It is well established that CsA through formation of a complex with cyclophilin inhibits the phosphatase activity of calcineurin, which regulates nuclear translocation and subsequent activation of NFAT transcription factors. In addition to the calcineurin/NFAT pathway, recent studies indicate that CsA also blocks the activation of JNK and p38 signaling pathways triggered by antigen recognition, making CsA a highly specific inhibitor of T cell activation. Here we discuss the action of CsA on JNK and p38 activation pathways. We also argue the potential of CsA and its natural counterparts as pharmacological probes.

[1]  F. Schmid,et al.  Protein folding: Prolyl isomerases join the fold , 1995, Current Biology.

[2]  B. Kahan.  Drug therapy: cyclosporine , 1989 .

[3]  M. Karin,et al.  Calcineurin preferentially synergizes with PKC‐θ to activate JNK and IL‐2 promoter in T lymphocytes , 1998, The EMBO journal.

[4]  Jonathan A. Cooper,et al.  Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. , 1995, Current opinion in cell biology.

[5]  F. Thaiss,et al.  CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTS , 1995, Transplantation.

[6]  Mark A Sussman,et al.  Prevention of cardiac hypertrophy in mice by calcineurin inhibition. , 1998, Science.

[7]  D. Cantrell,et al.  Networking Rho family GTPases in lymphocytes. , 1998, Immunity.

[8]  B. Ballermann,et al.  TGF-β and the endothelium during immune injury , 1997 .

[9]  S. Klahr,et al.  Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  P. Crespo,et al.  The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.

[11]  R. Davis,et al.  MAPKs: new JNK expands the group. , 1994, Trends in biochemical sciences.

[12]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[13]  D. Alexander,et al.  FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. , 1994, Cellular Immunology.

[14]  G. Crabtree.  Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.

[15]  J. Borel,et al.  Biological effects of cyclosporin A: A new antilymphocytic agent , 1976, Agents and actions.

[16]  P. Hogan,et al.  T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1 , 1996, Molecular and cellular biology.

[17]  W. Border,et al.  TGF-beta in kidney fibrosis: a target for gene therapy. , 1997, Kidney international.

[18]  G. Nolan,et al.  Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells , 1998, Cell.

[19]  E. A. O'neill,et al.  T cell responses in calcineurin A alpha-deficient mice , 1996, The Journal of experimental medicine.

[20]  J. Wu,et al.  A functional T-cell receptor signaling pathway is required for p95vav activity , 1995, Molecular and cellular biology.

[21]  T. Waldmann,et al.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Turner,et al.  The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Karin,et al.  Mitogen-activated protein kinase cascades and regulation of gene expression. , 1996, Current opinion in immunology.

[24]  Y. Ip,et al.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.

[25]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[26]  R. Flavell,et al.  AP‐1 transcriptional activity requires both T‐cell receptor‐mediated and co‐stimulatory signals in primary T lymphocytes. , 1994, The EMBO journal.

[27]  N. Sigal,et al.  FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. , 1991, Cellular immunology.

[28]  E. Clark,et al.  Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway. , 1997, Journal of immunology.

[29]  S. Shenolikar,et al.  Protein serine/threonine phosphatases--new avenues for cell regulation. , 1994, Annual review of cell biology.

[30]  P. Cohen.  The structure and regulation of protein phosphatases. , 1989, Annual review of biochemistry.

[31]  N. Sigal,et al.  Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? , 1991, The Journal of experimental medicine.

[32]  A. Villunger,et al.  Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL‐2 promoter activation in Jurkat T cells , 1999 .

[33]  E. Nishida,et al.  T Lymphocyte Activation Signals for Interleukin-2 Production Involve Activation of MKK6-p38 and MKK7-SAPK/JNK Signaling Pathways Sensitive to Cyclosporin A* , 1998, The Journal of Biological Chemistry.

[34]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[35]  H. Schaeffer,et al.  Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.

[36]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[37]  E. Price,et al.  Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4 , 1996, Nature.

[38]  Kengo Morimoto,et al.  Cyclosporine induces cancer progression by a cell-autonomous mechanism , 1999, Nature.

[39]  T. Pawson,et al.  HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. , 1996, The EMBO journal.

[40]  B. Ballermann,et al.  TGF-beta and the endothelium during immune injury. , 1997, Kidney international.

[41]  P. Hogan,et al.  Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  X. F. Zhang,et al.  Raf meets Ras: completing the framework of a signal transduction pathway. , 1994, Trends in biochemical sciences.

[43]  G. Crabtree,et al.  Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression , 1996, Nature.

[44]  S. Burakoff,et al.  Probing immunosuppressant action with a nonnatural immunophilin ligand , 1990, Science.

[45]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[46]  L. Goatley,et al.  A viral mechanism for inhibition of the cellular phosphatase calcineurin. , 1998, Science.

[47]  J. Woodgett,et al.  The stress activated protein kinase pathway. , 1996, Cancer surveys.

[48]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[49]  K. Herold,et al.  Immunosuppressive effects of cyclosporin A on cloned T cells. , 1986, Journal of immunology.

[50]  C. Crews,et al.  The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. , 1992, Science.

[51]  G. Nolan,et al.  NF-AT components define a family of transcription factors targeted in T-cell activation , 1994, Nature.

[52]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[53]  H. Youn,et al.  Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. , 1998, Immunity.

[54]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[55]  G. Crabtree,et al.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.

[56]  A. Granelli‐Piperno.  In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A , 1988, The Journal of experimental medicine.

[57]  T. L. Collins,et al.  Views on Vav. , 1997, Immunology today.

[58]  Masahiko Hibi,et al.  JNK is involved in signal integration during costimulation of T lymphocytes , 1994, Cell.

[59]  M. Karin,et al.  JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? , 1998 .

[60]  K. Blumer,et al.  Diversity in function and regulation of MAP kinase pathways. , 1994, Trends in biochemical sciences.

[61]  G. Crabtree,et al.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A , 1991, Nature.

[62]  M. Karin,et al.  Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. , 1998, Immunity.

[63]  E. A. O'neill,et al.  FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin , 1992, Nature.

[64]  W. Border,et al.  TGF-β in kidney fibrosis: A target for gene therapy , 1997 .

[65]  G. Crabtree,et al.  The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. , 1990, The EMBO journal.

[66]  K. Tedford,et al.  The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28‐mediated co‐stimulation , 1999, European journal of immunology.

[67]  W. Bennett,et al.  Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. , 1996, Kidney international.

[68]  M. Suthanthiran,et al.  Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction , 1991, The Journal of experimental medicine.

[69]  N. Ahn,et al.  Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.

[70]  M. Suthanthiran,et al.  Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. , 1994, Transplantation.

[71]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[72]  E. Nishida,et al.  The MAP kinase cascade is essential for diverse signal transduction pathways. , 1993, Trends in biochemical sciences.

[73]  S. Feller,et al.  Interaction of Hematopoietic Progenitor Kinase 1 with Adapter Proteins Crk and CrkL Leads to Synergistic Activation of c-Jun N-Terminal Kinase , 1999, Molecular and Cellular Biology.

[74]  T. Pawson,et al.  SH2/SH3 Adaptor Proteins Can Link Tyrosine Kinases to a Ste20-related Protein Kinase, HPK1* , 1997, The Journal of Biological Chemistry.